Integrated Psychiatric Services has a latest addition of Spravato® (esketamine) to our treatment options. As a groundbreaking nasal spray medication, Spravato® offers hope to patients with treatment-resistant depression. We are committed to providing comprehensive and innovative care to our patients, and the availability of Spravato® is a significant step forward in our mission to help individuals find relief from their mental health challenges.
What is Spravato?
The active ingredient in Spravato is esketamine, a newly approved form of ketamine. It represents a novel approach for those struggling with intractable depression.
Spravato is a revolutionary nasal spray offering hope for patients grappling with severe depression that hasn’t responded to traditional treatments. When used in conjunction with conventional antidepressants, Spravato can significantly alleviate depressive symptoms.
Unlike oral medications, Spravato is administered at specialized clinics. The healthcare professionals here moniter the patients closely to ensure their well-being and address any potential side effects.
Why would I need to take Spravato?
Spravato might be a suitable option for you if you:
-Have been diagnosed with major depressive disorder.
-Have tried at least two other antidepressant medications but haven’t experienced significant improvement in your symptoms.
-Are experiencing severe or treatment-resistant depression.
Spravato offers a unique approach that may be effective when other treatments have failed.
How many Spravato treatments would I need?
The number of Spravato treatments needed can vary from person to person. Factors such as the severity of your depression and your individual response to the medication will influence the treatment plan. Your healthcare provider will determine the optimal number of treatments based on your specific needs.